Chen-fang G. Lee

Taoyuan City, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Dendritic Cell Served as Salvage Therapy for Advanced Hepatocellular Carcinoma Resistant to Tyrosine Kinase or Immune Checkpoint Inhibitors.

Dendritic Cell Served as Salvage Therapy for Advanced Hepatocellular Carcinoma Resistant to Tyrosine Kinase or Immune Checkpoint Inhibitors.

Journal: Cancers

Published: March 26, 2026

Outcomes of Liver Transplantation Without Alcohol Abstinence in Alcohol-Associated Hepatitis With Original MELD Score ≥30.

Outcomes of Liver Transplantation Without Alcohol Abstinence in Alcohol-Associated Hepatitis With Original MELD Score ≥30.

Journal: Annals of transplantation

Published: March 10, 2026

Short-Term Semaglutide Improves Safety in High Body Weight Recipients Undergoing Living Donor Liver Transplant: A Case Report.

Short-Term Semaglutide Improves Safety in High Body Weight Recipients Undergoing Living Donor Liver Transplant: A Case Report.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: January 24, 2026

Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) without cirrhosis.

Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) without cirrhosis.

Journal: Annals of hepatology

Published: October 07, 2025

The Correlation of Hemodynamic Changes and Early Allograft Function Following Liver Transplantation.

The Correlation of Hemodynamic Changes and Early Allograft Function Following Liver Transplantation.

Journal: Transplantation proceedings

Published: August 21, 2025

A Simplified Risk Assessment Tool to Predict Post Deceased Donor Liver Transplantation Outcomes: A Single, Highly Experienced Medical Center in Taiwan.

A Simplified Risk Assessment Tool to Predict Post Deceased Donor Liver Transplantation Outcomes: A Single, Highly Experienced Medical Center in Taiwan.

Journal: The Kaohsiung journal of medical sciences

Published: June 06, 2025

Enhancement of allograft acceptance by combined dexmedetomidine and rapamycin.

Enhancement of allograft acceptance by combined dexmedetomidine and rapamycin.

Journal: Transplant immunology

Published: June 05, 2025

Pretransplant Immune Checkpoint Inhibitor Treatment for Intermediate-advanced Hepatocellular Carcinoma in Living Donor Liver Transplantation.

Pretransplant Immune Checkpoint Inhibitor Treatment for Intermediate-advanced Hepatocellular Carcinoma in Living Donor Liver Transplantation.

Journal: Transplantation direct

Published: April 07, 2025

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence.

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence.

Journal: Frontiers in immunology

Published: March 07, 2025

Hepatopulmonary Syndrome and Liver Transplantation: Impact on Survival and Postoperative Complications.

Hepatopulmonary Syndrome and Liver Transplantation: Impact on Survival and Postoperative Complications.

Journal: Annals of transplantation

Published: December 03, 2024

Disadvantage of Viable Portal Vein Tumor Thrombosis in Liver Transplantation for Advanced Hepatocellular Carcinoma.

Disadvantage of Viable Portal Vein Tumor Thrombosis in Liver Transplantation for Advanced Hepatocellular Carcinoma.

Journal: Cancers

Published: November 26, 2024

Does very high alpha-fetoprotein affect very early hepatocellular carcinoma receiving hepatectomy?

Does very high alpha-fetoprotein affect very early hepatocellular carcinoma receiving hepatectomy?

Journal: Langenbeck's archives of surgery

Published: October 28, 2024

Showing 1-12 of 94

Last Updated: 09/26/2026